4th Annual University of Utah Translational Hypertension Virtual Symposium
What: 4th Annual University of Utah Translational Hypertension Virtual Symposium
When: October 8, 2020, 9-11 AM
Where: Online - register here
Event Flyer: Click here for the symposium agenda
High blood pressure affects more than a billion people worldwide and remains a leading modifiable cause of heart disease and health disparities. The Coronavirus Disease 2019 (COVID-19) is likely the public health crisis of our lifetimes and has killed > 164,000 adults in the US alone as of August 14, 2020 as is altering the management of hypertension.
While everyone is impacted by COVID-19, not all are impacted equally. COVID-19 has laid bare the racial divide in the health of our nation. Distinctively, this crisis has highlighted the breadth of social and health inequities present in our country.
To help discuss these issues, we have reformatted the symposium into a virtual 90-minute panel discussion moderated by Dr. Daichi Shimbo focused on the intersection of the disparities in hypertension treatment and control laid bare by COVID-19 and the role of home blood pressure monitoring and telehealth during and after the COVID-19 pandemic.